[Gene methylation patterns in digestive tumors]

Area of Science:

• Molecular Oncology
• Epigenetics
• Gastrointestinal Cancer Research

Background:

• Loss of tumor suppressor gene function compromises genetic material integrity.
• Promoter gene methylation is a key mechanism for tumor suppressor gene inactivation.

Purpose of the Study:

• To investigate the methylation patterns of specific genes in gastrointestinal tumors.
• To correlate gene methylation with clinicopathological features and survival outcomes.

Main Methods:

• Analysis of biopsy samples from 48 gastric, 25 gallbladder, 24 colon, and 6 pancreas cancers.
• Methylation-specific polymerase chain reaction was used to assess CDH1, FHIT, CDKN2A, APC, and MLH1 gene methylation.
• Demographic, morphological, and follow-up data were analyzed alongside methylation patterns.

Main Results:

• High methylation frequencies observed for CDH1 (64.1%), FHIT (56%), CDKN2A (39.8%), MLH1 (34%), and APC (18.1%).
• Specific methylation patterns correlated with tumor differentiation, Lauren type, lymph node metastasis, and gender in gastric and gallbladder cancers.
• A trend towards reduced survival was noted in colon and gastric cancers with MLH1 and CDKN2A methylation, respectively.

Conclusions:

• Aberrant gene methylation is associated with distinct morphological features in gastric and gallbladder cancers.
• Gene methylation may indicate a tendency towards poorer survival in colon and gastric cancer patients.